Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
NCT05525481
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
ER+ Breast Cancer
Interventions
DRUG:
Tamoxifen
Sponsor
Erasmus Medical Center